{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:31:08Z","timestamp":1791419468902,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41429-022-00538-2","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T06:03:12Z","timestamp":1656309792000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium"],"prefix":"10.1038","volume":"75","author":[{"given":"Xiaoming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-2430","authenticated-orcid":false,"given":"Jinxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-2658","authenticated-orcid":false,"given":"Yiyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"538_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10:266\u201378.","journal-title":"Nat Rev Microbiol"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1586\/14787210.2014.870886","volume":"12","author":"V Cattoir","year":"2014","unstructured":"Cattoir V, Giard JC. Antibiotic resistance in Enterococcus faecium clinical isolates. Expert Rev Anti Infect Ther. 2014;12:239\u201348.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"538_CR3","doi-asserted-by":"crossref","unstructured":"Gotfried MH, Horn K, Garrity-Ryan L, Villano S, Tzanis E, Chitra S, et al. Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy adult subjects. Antimicrob Agents Chemother. 2017;61:e01135-17.","DOI":"10.1128\/AAC.01135-17"},{"key":"538_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1515\/hsz-2013-0292","volume":"395","author":"F Nguyen","year":"2014","unstructured":"Nguyen F, Starosta AL, Arenz S, Sohmen D, D\u00f6nh\u00f6fer A, Wilson DN. Tetracycline antibiotics and resistance mechanisms. Biol Chem. 2014;395:559\u201375.","journal-title":"Biol Chem"},{"key":"538_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1128\/AAC.04174-14","volume":"59","author":"V Cattoir","year":"2015","unstructured":"Cattoir V, Isnard C, Cosquer T, Odhiambo A, Bucquet F, Gu\u00e9rin. et al. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium. Antimicrob Agents Chemother. 2015;59:239\u201344.","journal-title":"Antimicrob Agents Chemother"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","volume":"80","author":"GG Zhanel","year":"2020","unstructured":"Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A. et al. Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent. Drugs. 2020;80:285\u2013313.","journal-title":"Drugs"},{"key":"538_CR7","doi-asserted-by":"crossref","unstructured":"Lin Z, Pu Z, Xu G, Bai B, Chen Z, Sun X, et al. Omadacycline efficacy against Enterococcus faecalis isolated in China: in vitro activity, heteroresistance, and resistance mechanisms. Antimicrob Agents Chemother 2020;64.","DOI":"10.1128\/AAC.02097-19"},{"key":"538_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1128\/AAC.01066-13","volume":"58","author":"MP Draper","year":"2014","unstructured":"Draper MP, Weir S, Macone A, Donatelli J, Trieber CA, Tanaka, Levy SBSK. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrob Agents Chemother. 2014;58:1279\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"538_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2217\/fmb-2016-0100","volume":"11","author":"S Villano","year":"2016","unstructured":"Villano S, Steenbergen J, Loh E. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections. Future Microbiol. 2016;11:1421\u201334.","journal-title":"Future Microbiol"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1016\/j.bmc.2016.07.029","volume":"24","author":"SK Tanaka","year":"2016","unstructured":"Tanaka SK, Steenbergen J, Villano S. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic. Bioorg Med Chem. 2016;24:6409\u201319.","journal-title":"Bioorg Med Chem"},{"key":"538_CR11","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Huband MD, Rhomberg PR, Flamm RK. Surveillance of omadacycline activity against clinical isolates from a global collection (North America, Europe, Latin America, Asia-Western Pacific), 2010\u20132011. Antimicrob Agents Chemother. 2017;61.","DOI":"10.1128\/AAC.00018-17"},{"key":"538_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2015.07.009","volume":"46","author":"M Niebel","year":"2015","unstructured":"Niebel M, Quick J, Prieto AM, Hill RL, Pike R, Huber D. et al. Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. Int J Antimicrob Agents. 2015;46:572\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12866-018-1349-7","volume":"18","author":"F Zhang","year":"2018","unstructured":"Zhang F, Bai B, Xu G, Lin Z, Li G, Chen Z. et al. Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance. BMC Microbiol. 2018;18:211","journal-title":"BMC Microbiol"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3389\/fmicb.2019.02546","volume":"10","author":"B Bai","year":"2019","unstructured":"Bai B, Lin Z, Pu Z, Xu G, Zhang F, Chen Z. et al. In vitro activity and heteroresistance of omadacycline against clinical Staphylococcus aureus isolates from China reveal the impact of omadacycline susceptibility by branched-chain amino acid transport system II carrier protein, Na\/Pi cotransporter family protein, and fibronectin-binding protein. Front Microbiol. 2019;10:2546","journal-title":"Front Microbiol"},{"key":"538_CR15","doi-asserted-by":"crossref","unstructured":"Bai B, Hu K, Li H, Yao W, Li D, Chen Z, et al. Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing. FEMS Microbiol Lett. 2018;365.","DOI":"10.1093\/femsle\/fnx284"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","volume":"382","author":"JA Jernigan","year":"2020","unstructured":"Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC. et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012\u20132017. N. Engl J Med. 2020;382:1309\u201319.","journal-title":"N. Engl J Med"},{"key":"538_CR18","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/jac\/dkn065","volume":"61","author":"G Werner","year":"2008","unstructured":"Werner G, Gfrorer S, Fleige C, Witte W, Klare I. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother. 2008;61:1182\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"538_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12941-015-0085-1","volume":"14","author":"DJ Hoban","year":"2015","unstructured":"Hoban DJ, Reinert RR, Bouchillon SK, Dowzicky MJ. Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004\u20132013. Ann Clin Microbiol Antimicrob. 2015;14:27.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"538_CR20","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/cid\/ciz395","volume":"69","author":"JA Karlowsky","year":"2019","unstructured":"Karlowsky JA, Steenbergen J, Zhanel GG. Microbiology and preclinical review of omadacycline. Clin Infect Dis : Off Publ Infect Dis Soc Am. 2019;69:S6\u201315.","journal-title":"Clin Infect Dis : Off Publ Infect Dis Soc Am"},{"key":"538_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232\u201360.","journal-title":"Microbiol Mol Biol Rev"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01242-13","volume":"58","author":"AB Macone","year":"2014","unstructured":"Macone AB, Caruso BK, Leahy RG, Donatelli J, Weir S, Draper MP. et al. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrob Agents Chemother. 2014;58:1127\u201335.","journal-title":"Antimicrob Agents Chemother"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/mcpr.2001.0363","volume":"15","author":"LK Ng","year":"2001","unstructured":"Ng LK, Martin I, Alfa M, Mulvey M. Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes. 2001;15:209\u201315.","journal-title":"Mol Cell Probes"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","volume":"49","author":"F McAleese","year":"2005","unstructured":"McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ. et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother. 2005;49:1865\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"538_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/jac\/dkv420","volume":"71","author":"S Fiedler","year":"2016","unstructured":"Fiedler S, Bender JK, Klare I, Halbedel S, Grohmann E, Szewzyk U. et al. Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M). J Antimicrob Chemother. 2016;71:871\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"538_CR26","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1128\/AAC.00547-15","volume":"59","author":"K Beabout","year":"2015","unstructured":"Beabout K, Hammerstrom TG, Perez AM, Magalhaes BF, Prater AG, Clements TP. et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob Agents Chemother. 2015;59:5561\u20135566.","journal-title":"Antimicrob Agents Chemother"},{"key":"538_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3389\/fmicb.2020.00916","volume":"11","author":"Z Wen","year":"2020","unstructured":"Wen Z, Shang Y, Xu G, Pu Z, Lin Z, Bai B. et al. Mechanism of eravacycline resistance in clinical Enterococcus faecalis Isolates from China. Front Microbiol. 2020;11:916","journal-title":"Front Microbiol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00538-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T11:08:08Z","timestamp":1657883288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1038\/s41429-022-00538-2","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"7 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were approved by the ethics committee of Shenzhen Shekou People\u2019s Hospital and Shenzhen Nanshan People\u2019s Hospital, in accordance with the ethical standards of Shenzhen University and the 1964 Helsinki declaration and its later amendments, or comparable ethical standards. Formal consent is not required for such study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}